Current Report Filing (8-k)
March 20 2014 - 5:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (date of earliest event
reported) March 19, 2014
FUSE SCIENCE, INC.
(Exact Name of Registrant as Specified
in Charter)
Nevada
(State or Other Jurisdiction
of Incorporation)
000-22991 |
|
87-0460247 |
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
|
|
6135 NW 167th Street, #E-21
Miami Lakes, Florida |
|
33015 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
(305) 503-3873
(Registrant’s telephone number,
Including Area Code)
Check the appropriate box if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 C.F.R 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 C.F.R 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 C.F.R 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 C.F.R 240.13e-4(c)) |
As used in this Current
Report on Form 8-K and unless otherwise indicated, the terms the “ Company ,” “ Fuse ,” “
we ,” “ us ,” and “ our ” refer to Fuse Science, Inc., unless the context requires
otherwise.
Item 5.07. Item 5.07 Submission of
Matters to a Vote of Security Holders.
On March 19, 2014,
the Company held a special meeting of shareholders (the “Meeting”).
As of January 31, 2014,
the record date for the Meeting, there were 319,915,143 shares of our common stock issued, outstanding, and entitled to vote.
At the Meeting, the
shareholders voted on the following two proposals and cast their votes as follows:
1. To approve an
amendment to the Company’s Articles of Incorporation to increase the number of shares of common stock authorized to be issued
by the Company from 400,000,000 to 800,000,000.
| |
FOR | | |
AGAINST | | |
ABSTAIN | |
# of Shares Cast/Voted | |
| 219,200,746 | | |
| 101,542,312 | | |
| 1,123,775 | |
2. To authorize
the board of directors of the Company to effect a reverse stock split of the Company’s common stock by a ratio of not less
than 1-for-50 and not more than 1-for-200, with the board of directors of the Company having the discretion as to whether or not
the reverse split is to be effected, and with the exact ratio of any reverse split to be set at a whole number within the above
range as determined by the Company’s board of directors in its discretion.
| |
FOR | | |
AGAINST | | |
ABSTAIN | |
# of Shares Cast/Voted | |
| 243,780,257 | | |
| 84,131,771 | | |
| 1,570,965 | |
Accordingly, both proposals
were approved.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
FUSE SCIENCE, INC. |
|
|
|
By: /s/ Brian Tuffin |
|
Brian Tuffin, Chief Executive Officer and Acting Chief |
|
Financial Officer |
Dated: March 20, 2014
REAC (CE) (USOTC:REAC)
Historical Stock Chart
From Aug 2024 to Sep 2024
REAC (CE) (USOTC:REAC)
Historical Stock Chart
From Sep 2023 to Sep 2024